Adenomyoma/adenomyomatosis-associated mural intracholecystic neoplasms: analysis of clinico-pathologic, imaging, and molecular features of a consecutive case series

腺肌瘤/腺肌瘤病相关壁内胆囊肿瘤:连续病例系列临床病理、影像学和分子特征分析

阅读:1

Abstract

Adenomyoma/adenomyomatosis (AM) of the gallbladder is generally considered an incidental and innocuous finding; however, neoplastic lesions, including intracholecystic neoplasms (ICNs), flat-type dysplasia, and carcinomas, may arise within AM. AM-associated ICNs, composed of mural cystically dilated glands containing florid papillary proliferations lined by mucinous and/or overtly dysplastic epithelium, are very rare and poorly characterized. This study aimed at investigating the clinico-radiologic, phenotypic/immunophenotypic, and molecular features of a mono-institutional case series of four AM-ICNs (0.2% of cholecystectomies). Immunohistochemistry for CDX2, MUC2, MUC5AC, MUC6, MUC1, HER2, ß-catenin, and p53, as well as next-generation sequencing of 110 tumor-related genes (AmoyDx® Comprehensive Panel), were performed. Our study confirms the AM-ICN-associated clinico-demographic characteristics previously described, including the relatively low frequency of associated invasive carcinoma (one case, 25%), although high-grade dysplasia (HGD) was observed in three out of four cases. In two cases, imaging findings suspicious for neoplasm were seen. Segmental-type AM was seen in two cases. Predominantly cell phenotype was gastric foveolar in two AM-ICNs and pancreatobiliary in the other two cases (both with HGD), while the immunophenotype was hybrid/mixed in all cases. No case had nuclear ß-catenin expression nor Wnt pathway or KRAS gene alterations. One case showed both HER2 point mutation and HER2 amplification, while the AM-ICN associated with an invasive adenocarcinoma harbored TP53 mutation and p53 overexpression. In conclusion, our findings suggest the separation of AM-ICNs from other gallbladder dysplastic lesions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。